523 results on '"Nomdedeu, Josep"'
Search Results
2. Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infection
3. Are silver-coated megaprostheses superior to uncoated megaprostheses in managing chronic end-stage periprosthetic hip and knee infection?
4. Predictors of outcomes after internal fixation of periprosthetic femoral hip fractures Subgroup analysis of the peri-implant and peri-prosthetic fractures Spanish registry (PIPPAS)
5. European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol
6. Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1
7. Engraftment characterization of risk-stratified AML in NSGS mice
8. The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients
9. Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial
10. Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification
11. Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia
12. Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to Therapy
13. Bone Marrow WT1 Levels in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplasia: Clinically Relevant Time Points and 100 Copies Threshold Value
14. Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes
15. P718: EPIGENOME PROFILING REVEALS ABERRANT DNA METHYLATION SIGNATURE IN GATA2 DEFICIENCY
16. P703: THE AIPSS-MDS MACHINE LEARNING MODEL PREDICTS OVERALL SURVIVAL AND LEUKEMIC TRANSFORMATION IN CMML: AN ANALYSIS OF THE SPANISH REGISTRY OF MDS
17. PB1923: NON-HEMATOLOGIC AUTOIMMUNE DISORDERS IN CLL: PREVALENCE AND PROGNOSTIC IMPACT IN A REAL-LIFE COHORT FROM A SINGLE-CENTRE
18. Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes
19. Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies
20. Erytrocyte-related phenotypes and genetic susceptibility to thrombosis
21. Supplementary Data from Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome
22. Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency
23. Genetic determinants of Platelet Large-Cell Ratio, Immature Platelet Fraction, and other platelet-related phenotypes
24. Supervised Machine Learning Improves Risk Stratification in Newly Diagnosed Myelodysplastic Syndromes: An Analysis of the Spanish Group of Myelodysplastic Syndromes
25. RAS Mutations in Adult Acute Myeloid Leukemia (AML). Frequency, Mutational Spectrum, and Identification of a Comutation Bias for KRASK117 (TET2/ASXL1)
26. Bone Marrow WT1 mRNA Upregulation in Acute Myeloid Leukemia (AML) in Complete Molecular Remission (mCR): Understanding the Limitations and Advantages of WT1 As a Measurable Residual Disease (MRD) Target
27. Evolution in the frontline treatment of patients with chronic lymphocytic leukemia: experience from one European center.
28. Determinacions del perfil genètic de les malalties neoplàstiques hematològiques
29. Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
30. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high‐hyperdiploid B‐cell acute lymphoblastic leukemia
31. Many signs, one mutation: Early onset of de novo GATA2 deficiency syndrome. A case report
32. Author response for 'Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia'
33. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia
34. Engraftment characterization of risk-stratified AML patients in NSGS mice
35. The Notch/Hes1 Pathway Sustains NF-κB Activation through CYLD Repression in T Cell Leukemia
36. An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens
37. WT1 monitoring in core binding factor AML: Comparison with specific chimeric products
38. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols
39. CEBPA bZip mutations: just a single shot
40. ALL-154: t(1;19)(q23;p13) TCF3-PBX1 May Not Be an Intermediate-Risk Subtype in Adult B-Cell Precursor Acute Lymphoblastic Leukemia Patients Treated With MRD-Oriented Protocols from the PETHEMA Group
41. Poster: ALL-154: t(1;19)(q23;p13) TCF3-PBX1 May Not Be an Intermediate-Risk Subtype in Adult B-Cell Precursor Acute Lymphoblastic Leukemia Patients Treated With MRD-Oriented Protocols from the PETHEMA Group
42. Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group
43. Subcutaneous passage increases cell aggressiveness in a xenograft model of diffuse large B cell lymphoma
44. Ubtf tandem Duplications Define a Novel Subtype of Acute Myeloid Leukemia Associated with Younger Age, WT1 Mutations and HOXA9 Marked Overexpression
45. Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias
46. K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML)
47. Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1
48. FcγRIIb-BCR co-ligation inhibits B-cell receptor signaling in chronic lymphocytic leukemia
49. Role of the Polycomb Repressive Complex 2 in Acute Promyelocytic Leukemia
50. The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.